Drug Research
Abzena announces opening of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors
Abzena, a Global Partner Research Organization for integrated bench to market solutions for biologics and bioconjugates, has announced the addition of a 6th Global site that will augment cGMP manufacturing capacity for mammalian biologics. This expansion is driven by...
News
AMRI Included in BARDA CDMO Network in Support of COVID-19 Pandemic Response in the U.S.
Albany Molecular Research, Inc. (AMRI), a leading global provider of advanced contract research, development and manufacturing solutions, announced its Albuquerque, New Mexico, facility has been approved for inclusion in the Biomedical Advanced Research and Development Authority (BARDA) contract development...
Clinical Trials
CureVac’s COVID-19 Vaccine Demonstrated Efficient Protection of Non-Human Primates During SARS-CoV-2 Challenge Infection
CureVac N.V., a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), announced the publication of preclinical data demonstrating the induction of robust antibody and T cell responses of its COVID-19 vaccine...
News
Algeria has become the first country in Africa to register Sputnik V vaccine
The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces the registration of the Russian Sputnik V vaccine against coronavirus by the National Agency of Pharmaceutical Products of People's Democratic Republic of Algeria.
The vaccine was registered under the...
News
AvantGen Announces Licensing of Its Anti-SARS-CoV-2 Antibodies to IGM Biosciences for COVID-19 Therapy Development
AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation, announced licensing of a panel of its anti-SARS-CoV-2 antibody clones to IGM Biosciences...
News
Kuehne+Nagel finalises agreement with Moderna for Covid-19 vaccine distribution
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, and Kuehne+Nagel, a world-leading logistics company, announced that they have agreed an international supply chain arrangement to provide distribution and storage of the Covid-19 Vaccine Moderna. This...
Clinical Trials
Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine
Dr Reddy’s Laboratories (DRL) on Monday announced the start of its phase 3 clinical trial of Russia's Sputnik V Covid-19 vaccine after receiving clearance from the independent Data and Safety Monitoring Board (DSMB).
DSMB’s clearance is based on the safety...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.